Fused ring thrombin receptor antagonists
AssigneeMerck Sharp & Dohme Corp.
InventorsYan Xia, Mariappan V. Chelliah, Samuel Chackalamannil
Life of this patent
Estimating the term…
Loading patent…
AssigneeMerck Sharp & Dohme Corp.
InventorsYan Xia, Mariappan V. Chelliah, Samuel Chackalamannil
Estimating the term…
Fused-ring, heterocyclic-substituted tricyclics of the formula or a pharmaceutically acceptable salt or solvate of said compound, isomer or racemic mixture wherein represents an optional double bond, and wherein An, En, Mn, Gn, Jn, R3, n7, R8, R9, R10, R11, R32, R33, X, Y, B and Het are herein defined and the remaining substituents are as defined in the specification, are disclosed, as well as pharmaceutical compositions containing them and a method of treating diseases associated with thrombosis, atherosclerosis, restenosis, hypertension, angina pectoris, arrhythmia, heart failure, and cancer by administering said compounds. Combination therapy with other cardiovascular agents is also claimed.
A compound represented by structural formula I:
(canceled)
(canceled)
(canceled)
(canceled)
27-30. (canceled)
39-44. (canceled)
Dependencies are inferred from the claim text.